Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.

Dietz AC, Mehta PA, Vlachos A, Savage SA, Bresters D, Tolar J, Boulad F, Dalle JH, Bonfim C, de la Fuente J, Duncan CN, Baker KS, Pulsipher MA, Lipton JM, Wagner JE, Alter BP.

Biol Blood Marrow Transplant. 2017 May;23(5):726-735. doi: 10.1016/j.bbmt.2017.01.075. Epub 2017 Jan 20. Review.

PMID:
28115275
2.

Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia.

Thakar MS, Bonfim C, Walters MC, Storb R, Pasquini R, Burroughs L, Sandmaier BM, Woolfrey A, Kiem HP.

Bone Marrow Transplant. 2017 Apr;52(4):570-573. doi: 10.1038/bmt.2016.301. Epub 2017 Jan 9.

3.

Interleukin 8/KC enhances G-CSF induced hematopoietic stem/progenitor cell mobilization in Fancg deficient mice.

Li Y, Xing W, He YZ, Chen S, Rhodes SD, Yuan J, Zhou Y, Shi J, Bai J, Zhang FK, Yuan WP, Cheng T, Xu MJ, Yang FC.

Stem Cell Investig. 2014 Oct 31;1:19. doi: 10.3978/j.issn.2306-9759.2014.10.02. eCollection 2014.

4.

Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.

Anur P, Friedman DN, Sklar C, Oeffinger K, Castiel M, Kearney J, Singh B, Prockop SE, Kernan NA, Scaradavou A, Kobos R, Curran K, Ruggiero J, Zakak N, O'Reilly RJ, Boulad F.

Bone Marrow Transplant. 2016 Jul;51(7):938-44. doi: 10.1038/bmt.2016.32. Epub 2016 Mar 21.

5.

Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure.

Ayas M, Eapen M, Le-Rademacher J, Carreras J, Abdel-Azim H, Alter BP, Anderlini P, Battiwalla M, Bierings M, Buchbinder DK, Bonfim C, Camitta BM, Fasth AL, Gale RP, Lee MA, Lund TC, Myers KC, Olsson RF, Page KM, Prestidge TD, Radhi M, Shah AJ, Schultz KR, Wirk B, Wagner JE, Deeg HJ.

Biol Blood Marrow Transplant. 2015 Oct;21(10):1790-5. doi: 10.1016/j.bbmt.2015.06.012. Epub 2015 Jun 23.

6.

Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.

Stenger EO, Chiang KY, Haight A, Qayed M, Kean L, Horan J.

Biol Blood Marrow Transplant. 2015 Oct;21(10):1845-52. doi: 10.1016/j.bbmt.2015.06.005. Epub 2015 Jun 19.

7.

Alternative donor hematopoietic cell transplantation for Fanconi anemia.

MacMillan ML, DeFor TE, Young JA, Dusenbery KE, Blazar BR, Slungaard A, Zierhut H, Weisdorf DJ, Wagner JE.

Blood. 2015 Jun 11;125(24):3798-804. doi: 10.1182/blood-2015-02-626002. Epub 2015 Mar 30.

8.

Alternative donor transplant of benign primary hematologic disorders.

Tolar J, Sodani P, Symons H.

Bone Marrow Transplant. 2015 May;50(5):619-27. doi: 10.1038/bmt.2015.1. Epub 2015 Feb 9. Review.

9.

New frontiers in pediatric Allo-SCT.

Talano JM, Pulsipher MA, Symons HJ, Militano O, Shereck EB, Giller RH, Hancock L, Morris E, Cairo MS.

Bone Marrow Transplant. 2014 Sep;49(9):1139-45. doi: 10.1038/bmt.2014.89. Epub 2014 May 12. Review.

10.

Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia.

Mitchell R, Wagner JE, Hirsch B, DeFor TE, Zierhut H, MacMillan ML.

Br J Haematol. 2014 Feb;164(3):384-95. doi: 10.1111/bjh.12634. Epub 2013 Oct 30.

11.

Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens.

Patel SR, Zimring JC.

Transfus Med Rev. 2013 Oct;27(4):241-8. doi: 10.1016/j.tmrv.2013.08.002. Epub 2013 Oct 3. Review.

12.
13.

Determination of intracellular fludarabine triphosphate in human peripheral blood mononuclear cells by LC-MS/MS.

Huang L, Lizak P, Aweeka F, Long-Boyle J.

J Pharm Biomed Anal. 2013 Dec;86:198-203. doi: 10.1016/j.jpba.2013.08.007. Epub 2013 Aug 23.

14.

Bone marrow transplantation in Schimke immuno-osseous dysplasia.

Baradaran-Heravi A, Lange J, Asakura Y, Cochat P, Massella L, Boerkoel CF.

Am J Med Genet A. 2013 Oct;161A(10):2609-13. doi: 10.1002/ajmg.a.36111. Epub 2013 Aug 15. Review.

15.

The use of haematopoietic stem cell transplantation in Fanconi anaemia patients: a survey of decision making among families in the US and Canada.

Hutson SP, Han PK, Hamilton JG, Rife SC, Al-Rahawan MM, Moser RP, Duty SP, Anand S, Alter BP.

Health Expect. 2015 Oct;18(5):929-41. doi: 10.1111/hex.12066. Epub 2013 Apr 29.

16.

Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia.

Ayas M, Saber W, Davies SM, Harris RE, Hale GA, Socie G, LeRademacher J, Thakar M, Deeg HJ, Al-Seraihy A, Battiwalla M, Camitta BM, Olsson R, Bajwa RS, Bonfim CM, Pasquini R, Macmillan ML, George B, Copelan EA, Wirk B, Al Jefri A, Fasth AL, Guinan EC, Horn BN, Lewis VA, Slavin S, Stepensky P, Bierings M, Gale RP.

J Clin Oncol. 2013 May 1;31(13):1669-76. doi: 10.1200/JCO.2012.45.9719. Epub 2013 Apr 1.

17.

Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.

Thakar MS, Bonfim C, Sandmaier BM, O'Donnell P, Ribeiro L, Gooley T, Deeg HJ, Flowers ME, Pasquini R, Storb R, Woolfrey AE, Kiem HP.

Pediatr Hematol Oncol. 2012 Sep;29(6):568-78. doi: 10.3109/08880018.2012.708708. Epub 2012 Jul 27.

18.

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.

Horan J, Wang T, Haagenson M, Spellman SR, Dehn J, Eapen M, Frangoul H, Gupta V, Hale GA, Hurley CK, Marino S, Oudshoorn M, Reddy V, Shaw P, Lee SJ, Woolfrey A.

Blood. 2012 Oct 4;120(14):2918-24. doi: 10.1182/blood-2012-03-417758. Epub 2012 Jul 24.

19.

Chromosomal aberrations associated with clonal evolution and leukemic transformation in fanconi anemia: clinical and biological implications.

Meyer S, Neitzel H, Tönnies H.

Anemia. 2012;2012:349837. doi: 10.1155/2012/349837. Epub 2012 May 23.

20.

Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines.

Scheckenbach K, Wagenmann M, Freund M, Schipper J, Hanenberg H.

Klin Padiatr. 2012 Apr;224(3):132-8. doi: 10.1055/s-0032-1308989. Epub 2012 Apr 13. Review.

Supplemental Content

Support Center